Comparison CompoundClassPathway / targetResearch focusFormat BPC-157Gastric pentadecapeptideCytoprotection / angiogenesisGut & soft-tissue repairVial TB-500Thymosin beta-4 peptideActin binding / cell migrationWound & tendon repairVial TB-500 (Frag)Thymosin beta-4 fragmentActin-binding domainCell migration researchVial BPC-157 + TB-500Peptide blendCytoprotection + actin signallingCombined repair researchVial GLOWPeptide blendCopper-peptide + repair peptidesDermal & connective-tissue researchVial KLOWPeptide blendRepair peptides + anti-inflammatoryCombined repair & inflammation researchVial BPC-157 Arginate CapsulesGastric pentadecapeptide (salt form)Cytoprotection / angiogenesisOral-route repair researchCapsules BPC-157 Arginate + TB-500 CapsulesPeptide blend (salt form)Cytoprotection + actin signallingOral-route combined researchCapsules TB-500 CapsulesThymosin beta-4 peptideActin binding / cell migrationOral-route repair researchCapsules Every compound in this category is supplied as Research Use Only material with: Peer-reviewed literature underpinning this category

The Purpose of a Subcutaneous Injection A subcutaneous injection is often used for medications absorbed slowly and steadily into the bloodstream
Gastrectomy for any reason (eg, gastric cancer, bariatric surgery) increases the risk of deficiency because parietal cells, the source of intrinsic factor, are removed (17
TB-500s systemic distribution supports healing throughout the thoracic region while BPC-157 provides targeted support at the primary injury site
Keep the vial upright, away from light, and discard any solution that becomes cloudy, discolored, or develops particles
Within 48 hours after injection of 100 or 1,000 mcg of vitamin B 12 , 50 to 98% of the injected dose may appear in the urine